Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|medical science|immunology · SOCIAL QUESTIONS|health|pharmaceutical industry · SOCIAL QUESTIONS|health|illness|cancer

    #689681

    IATE #3644693
    bacainn seicphointí Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    checkpoint blockade
    en
    Sainmhíniú "major strategy in cancer immunotherapy which involves blocking the action of immune checkpoints, essentially taking the brakes off cancer-fighting T cells" Tagairt "COM-Terminology Coordination, based on: UCIR. 'Checkpoint Blockade' (3.5.2024)"
    Nóta Currently, the immune checkpoints that are most targeted in immunotherapy are CTLA-4 and PD-1. Two of the researchers, Drs James P. Allison and Tasuku Honjo, who pioneered the study of these checkpoint blockades, received the Nobel Prize in Physiology or Medicine in 2018.